Drugs / RECOFLAVONE
RECOFLAVONE
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01162954 | Sep 2008 → Mar 2009 | dry eye syndrome | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01670357 | Apr 2012 → Mar 2013 | dry eye syndrome | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01813812 | Oct 2010 → Aug 2013 | chronic gastritis | Dong-A Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RECOFLAVONE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297606 ↗ |
| Known as | DA-6034 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01162954 ↗ |
| Known as | Recoflavona | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297606 ↗ |
| Modality | Small molecule | — CHEMBL4297606 ↗ |
| Route | Topical | “repeated-dose topical application” NCT01162954 ↗ |